Partnerships with manufacturers to implement innovative contract models across pharmacy and medical benefits. Evio has already demonstrated success through direct purchase and value-based contracts with multiple manufacturers, creating opportunities for expanded access while delivering cost savings for health plans, employers, and patients.
Real-world evidence research derived from highly curated pharmacy and medical claims data to provide manufacturers with valuable insights into addressable populations, patient journeys, and medication effectiveness outcomes across disease states.
A portfolio of services and digital tools to support opportunities for adoption of high-value pharmaceutical products by Evio owner health plans and their members through enhanced support of patients and providers as they navigate a medication transition.
Evio Access offerings are powered by Evio’s leading real-world-evidence capability: analyzing over 1 billion claims across more than 35 million lives and providing unparalleled insights into patient outcomes and medication effectiveness.
Evio’s owner health plans are innovation-minded organizations with significant presence in critical, dense markets across the United States. This market density ensures that Evio and our pharma manufacturer partners can deliver valuable data-driven solutions for patients.
Working with Evio removes intermediaries and layers of complexity that can impact net revenue for manufacturers through hidden fees. Evio’s model brings manufacturers closer to the ultimate payer and decision maker: the health plan and their customers.
Evio acts an extension of its owner health plans and can create offers at scale that are presented to those owner plans, with a health plan class of trade (not PBM or GPO) for both medical and pharmacy benefit medications.
Evio and its owner health plans are committed to implementing innovative business models with pharma manufacturers that focus on improving patient outcomes and reducing total cost of care.
Evio is a valuable partner for pharmaceutical manufacturers to optimize their market strategies and create opportunities for improved treatment access while helping to enable our vision that every patient should have access to the right medication for their unique situation, from the beginning, in a simple and affordable way.
